An experimental vaccine for hepatitis E has proved nearly 96 percent protective in a test among soldiers in Nepal. The results set the stage for a final trial that could lead to commercialization of the vaccine, the first to be developed against this virus.
Other hepatitis vaccines don’t work against hepatitis E, and there’s no effective treatment for the disease that it causes.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.